First-in-human study on pharmacokinetics, safety, and tolerability of single and multiple escalating doses of PA9159 nasal spray, a highly potent glucocorticoid in healthy Chinese volunteers
S Guo(Beijing Tongren Hospital), Luo Zhang(Hebei Medical University), Yingchun Hu(Southwest Medical University), Siyang Ni(Beijing Tongren Hospital), Xiuli Zhao(Beijing Tongren Hospital), Yuan Zhang(Guangzhou Medical University), Laichun Lu(Army Medical University), Ying Han(Fujian University of Traditional Chinese Medicine), Chunping Lu(Jazz Pharmaceuticals (United States)), Feng Wu(Beijing Tongren Hospital), Minwan Hu(Beijing Tongren Hospital), Zhijian Xi(Jazz Pharmaceuticals (United States)), Yuyang Dai(Beijing Tongren Hospital), Chengshuo Wang(Chinese Academy of Sciences)
Cited by 0
Related Papers
American Society of Hematology 2020 Guidelines for Management of Venous Thromboembolism: Treatment of Deep Vein Thrombosis and Pulmonary Embolism
|Blood Advances|2020|1.4k
Chinese Society of Allergy Guidelines for Diagnosis and Treatment of Allergic Rhinitis
|Allergy Asthma and Immunology Research|2018|383
Allergen immunotherapy for allergic rhinoconjunctivitis: A systematic review and meta‐analysis
|Allergy|2017|360
Increased neutrophilia in nasal polyps reduces the response to oral corticosteroid therapy
|Journal of Allergy and Clinical Immunology|2012|304